TG Therapeutics
TGTX
TGTX
97 hedge funds and large institutions have $359M invested in TG Therapeutics in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+6
Holders Change %
+6.59%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
30
Increased
37
Reduced
18
Closed
18
Calls
$8.13M
Puts
$4.67M
Net Calls
+$3.45M
Net Calls Change
+$4.17M
Top Buyers
| 1 |
1
BlackRock
New York
|
$31.1M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$75.2M |
| 3 |
3
Franklin Resources
San Mateo,
California
|
$22.6M |
| 4 |
4
Jennison Associates
New York
|
$16M |
| 5 |
SAM
5
Senzar Asset Management
New York
|
$13.3M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
101
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$180K | -38,622 | Closed |
|
|
WMSA
102
Weiss Multi-Strategy Advisers
New York
| – | -$140K | -30,000 | Closed |
|
|
EMG
103
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$137K | -29,500 | Closed |
|
104
Mariner
Overland Park,
Kansas
| – | -$112K | -24,116 | Closed |
|
|
FRM
105
Fox Run Management
Greenwich,
Connecticut
| – | -$86K | -18,600 | Closed |
|
106
Wolverine Trading
Chicago,
Illinois
| – | -$56K | -12,090 | Closed |
|
|
ID
107
Integral Derivatives
New York
| – | -$56K | -11,975 | Closed |
|
|
TCM
108
Teza Capital Management
Chicago,
Illinois
| – | -$48K | -10,278 | Closed |
|
|
PHK
109
Point72 Hong Kong
Hong Kong
| – | -$21K | -4,485 | Closed |
|
|
MA
110
MUFG Americas
New York
| – | -$6K | -1,206 | Closed |
|
|
IA
111
IFP Advisors
Tampa,
Florida
| – | -$5K | -1,000 | Closed |
|
|
TRCT
112
Tower Research Capital (TRC)
New York
| – | -$2K | -527 | Closed |
|